Open innovation challenge for Sustainable materials solutions

Rubbers & plastics for the automotive industry

1 Min
More

SCIENION continues to grow and will build new headquarters in Berlin Adlershof

SCIENION AG, located in the Technology Park Adlershof since its foundation in 2001, today announced that the expanding company will build larger new headquarters at Wagner-Régeny Street in the same district of Berlin.

2 Min
More

GeneQuine Biotherapeutics Secures More Than €9 Million in Series A Financing and Non-Dilutive Funding to Advance Gene Therapy Pipeline for Musculoskeletal Diseases

• Proceeds will facilitate development of GeneQuine’s gene therapy pipeline for musculoskeletal disorders and vector platform

• Lead gene therapy candidate GQ-303, a potentially disease-modifying treatment for osteoarthritis, will be advanced to…

7 Min
More

Glycotope announces licensing agreement with ONK Therapeutics for humanized GlycoBody targeting TA-MUC1

GlycoBody to be integrated into ONK pre-clinical program ONKT103, for solid tumors.

3 Min
More

Alrise announces acquisition of its ImSus® drug delivery technology by Ferring International Center S.A.

 

The drug delivery specialist Alrise Biosystems GmbH has entered into an Asset Purchase and Exclusive License Agreement with Ferring International Center S.A. for the development and commercialisation of products manufactured with Alrise’s ImSus®…

1 Min
More

Adrenomed closes EUR 22 million equity financing to accelerate development of Adrecizumab (HAM8101) and provides business update

- Series E round led by existing top-tier life science investors Wellington Partners and HBM Healthcare Investments

- Data from AdrenOSS-2 on early treatment start with Adrecizumab in septic shock to be presented at DIVI, December 2-4, 2020

3 Min
More

COVID-19: Despite the prospect of vaccines, tests are the tool of choice

- Virologists and epidemiologists call for continuous testing to contain the pandemic

- The DiagnostikNet-BB works on many levels of the test chain

- IMDB develops new project family for comprehensive COVID-19 diagnostics

2 Min
More

Asahi Kasei Pharma contracts ProBioGen for the Advancement of their Biologics Pipeline

 

ProBioGen AG announced the closing of a master service agreement with Asahi Kasei Pharma. As an expert CDMO in high-titer cell line development till large scale GMP manufacturing, ProBioGen will use its proprietary technologies, like the…

2 Min
More

IMMUTEP ANNOUNCES AUSTRALIAN PATENT GRANT FOR IMP701 ANTIBODY

Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or the “Company”) announces 2015229103 entitled “Antibody molecules to LAG- 3 and uses thereof” by the Australian Patent Office.

3 Min
More

Eternygen Announces the First Closing of its Series A2 Funding Round

Eternygen announces today the first closing of its Series A2 funding round led by new anchor investor Evotec SE and additional funding from venture capital firms Epidarex Capital, IBB Ventures and a number of family offices. The new investment…

4 Min
More
Show more items